abstract |
The present invention provides chemical entities or compounds capable of modulating protein kinases such as mTor, tyrosine kinases and/or lipid kinases such as PI3 kinase and pharmaceutical compositions thereof. The invention also provides methods of modulating the activity of one or more of these kinases using these compositions, particularly for therapeutic applications. |